Brendan Luu

Insider Reports History

Entity
Individual
Location
C/O Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA
Signature
/s/ Matthew Kowalsky as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brendan Luu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC Chief Business Officer Common Stock 36K $291K $8.06 Dec 6, 2024 Direct
ENANTA PHARMACEUTICALS INC Chief Business Officer Stock Option (right to buy) 75K Nov 27, 2024 Direct

Insider Reports Filed by Brendan Luu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENTA ENANTA PHARMACEUTICALS INC Dec 6, 2024 1 -$18.4K 4 Dec 10, 2024 Chief Business Officer
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2024 1 -$6.48K 4 Dec 3, 2024 Chief Business Officer
ENTA ENANTA PHARMACEUTICALS INC Nov 27, 2024 1 $0 4 Nov 27, 2024 Chief Business Officer
ENTA ENANTA PHARMACEUTICALS INC Feb 12, 2024 2 -$12.1K 4 Feb 14, 2024 Chief Business Officer
ENTA ENANTA PHARMACEUTICALS INC Dec 5, 2023 1 -$20.5K 4 Dec 6, 2023 Sr. VP, Business Dev.
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2023 1 -$7.15K 4 Dec 5, 2023 Sr. VP, Business Dev.
ENTA ENANTA PHARMACEUTICALS INC Nov 22, 2023 1 $0 4 Nov 22, 2023 Sr. VP, Business Dev.
ENTA ENANTA PHARMACEUTICALS INC Feb 13, 2023 3 -$339K 4 Feb 15, 2023 Sr. VP, Business Dev.
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2022 1 -$22.1K 4 Dec 5, 2022 Sr. VP, Business Dev.
ENTA ENANTA PHARMACEUTICALS INC Nov 23, 2022 2 $0 4 Nov 28, 2022 Sr. VP, Business Dev.
ENTA ENANTA PHARMACEUTICALS INC Feb 14, 2022 3 -$30.6K 4 Feb 15, 2022 Sr. VP, Business Dev.
ENTA ENANTA PHARMACEUTICALS INC Nov 19, 2021 2 $0 4 Nov 23, 2021 Sr. VP, Business Dev.